Dr Fabio D'Agostino

Dr. Fabio D'Agostino is a Global Consultant & Bio-Tech Specialist with expertise in identifying and evaluating new assets, products, services, and business models within the biopharmaceutical, cell & gene therapy medicinal industries.

He is skilled at accessing new markets through the acquisition of dedicated facilities, driving growth and increasing demand for companies.

As an External Advisor, Dr. D'Agostino has supported clients in business expansion, providing sector commercial analysis, strategic decision-making plans, and market opportunity insights.

He successfully aided clients in accessing new markets through strategic acquisitions such as dedicated cell therapy manufacturing facilities.

Dr. D'Agostino excels in enhancing portfolios through acquisition research, analysis, and reporting, providing clients with detailed reports for informed acquisition reviews at the Board level.

Passionate about developing feasibility plans for funding new technologies and companies, he maps competitive landscapes to define TPP and secure funding for startup ventures.

His key skills include evaluating business and sector opportunities, working on cell & gene therapy projects, commercialization of science, market and competitor analysis, financial modeling, and strategic alliance development.

Dr. D'Agostino has a strong educational background with an Engineering Doctorate in Biopharmaceutical Process Development, a Master of Science in Biomedical Engineering, and a Bachelor of Science in Biomedical Engineering.

He has held various roles in organizations including CEO and Founder at CharaBio, Venture Partner at Claris Ventures SGR SpA, Partner at Alira Health, and Consultant at International Lean Six Sigma Institute (iLSSi).

Dr. D'Agostino has also worked as a Research Associate at Newcastle University, Research Analyst at Informa Life Sciences, and in roles involving business development, writing, and event management in the biopharmaceutical industry.